209 related articles for article (PubMed ID: 25659743)
1. Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.
Christianson DR; Dobroff AS; Proneth B; Zurita AJ; Salameh A; Dondossola E; Makino J; Bologa CG; Smith TL; Yao VJ; Calderone TL; O'Connell DJ; Oprea TI; Kataoka K; Cahill DJ; Gershenwald JE; Sidman RL; Arap W; Pasqualini R
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2521-6. PubMed ID: 25659743
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma.
Rebhun RB; Cheng H; Gershenwald JE; Fan D; Fidler IJ; Langley RR
Neoplasia; 2010 Feb; 12(2):173-82. PubMed ID: 20126475
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
5. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
6. From tumor lymphangiogenesis to lymphvascular niche.
Hirakawa S
Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
8. DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells.
Alve S; Gramolelli S; Jukonen J; Juteau S; Pink A; Manninen AA; Hänninen S; Monto E; Lackman MH; Carpén O; Saharinen P; Karaman S; Vaahtomeri K; Ojala PM
JCI Insight; 2024 Jan; 9(1):. PubMed ID: 37971882
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes.
Pasquali S; van der Ploeg AP; Mocellin S; Stretch JR; Thompson JF; Scolyer RA
Pigment Cell Melanoma Res; 2013 May; 26(3):326-37. PubMed ID: 23298266
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic vessels regulate immune microenvironments in human and murine melanoma.
Lund AW; Wagner M; Fankhauser M; Steinskog ES; Broggi MA; Spranger S; Gajewski TF; Alitalo K; Eikesdal HP; Wiig H; Swartz MA
J Clin Invest; 2016 Sep; 126(9):3389-402. PubMed ID: 27525437
[TBL] [Abstract][Full Text] [Related]
12. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis.
Shayan R; Karnezis T; Murali R; Wilmott JS; Ashton MW; Taylor GI; Thompson JF; Hersey P; Achen MG; Scolyer RA; Stacker SA
Histopathology; 2012 Oct; 61(4):702-10. PubMed ID: 22734806
[TBL] [Abstract][Full Text] [Related]
14. Tumor metastasis and the lymphatic vasculature.
Sleeman JP; Thiele W
Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
[TBL] [Abstract][Full Text] [Related]
15. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
16. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
17. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
18. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma.
Pastushenko I; Van den Eynden GG; Vicente-Arregui S; Prieto-Torres L; Alvarez-Alegret R; Querol I; Dirix LY; Carapeto FJ; Vermeulen PB; Van Laere SJ
Am J Dermatopathol; 2016 May; 38(5):338-46. PubMed ID: 26909582
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
20. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes.
Leary N; Walser S; He Y; Cousin N; Pereira P; Gallo A; Collado-Diaz V; Halin C; Garcia-Silva S; Peinado H; Dieterich LC
J Extracell Vesicles; 2022 Feb; 11(2):e12197. PubMed ID: 35188342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
